Skip to content
  • Baker Lab
  • Bhardwaj lab
  • DiMaio Lab
  • Gu Lab
  • King Lab
  • Foldit
Institute for Protein Design

Institute for Protein Design

  • News
  • Research
    • Basic Areas
    • Applications
    • Translational Program
    • COVID-19
  • Audacious Project
  • Get Involved
    • Join us
    • Employment
    • Community
    • Give
  • Impact & Outreach
    • Impact
    • Videos
  • In the Media
  • About
    • Faculty and Staff
    • Core Labs
    • Advisory Board
    • Contributors
    • Contact
February 5, 2014

A New Vaccine Design Method To Combat A Dangerous Virus

Rosetta FFL In a widely cited Nature paper entitled Proof of principle for epitope-focused vaccine design, IPD researchers and collaborators invented a new method to design novel proteins for use as a candidate vaccines to protect against respiratory syncytial virus (RSV), a significant cause of infant mortality.  Learn more at this link.

  • IPD Publication
  • respiratory syncytial virus
  • Rosetta
  • Vaccine
Post navigation
A Computationally Designed Metalloprotein Using an Unnatural Amino Acid
Seattle Health Innovators Visit the IPD
© Institute for Protein Design, University of Washington
  • Twitter
  • YouTube
  • Email